Skip to main content
EJNMMI Research
Fig. 7 | EJNMMI Research

Fig. 7

From: Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1

Fig. 7

Expression of SSTR1–5 in GOT1 tumors after 177Lu-octreotate exposure. Gene expression of SSTR1–5 relative to GAPDH and TUBB analyzed by qRT-PCR in GOT1 tumors. Tumors were analyzed 1, 3, and 7 days after treatment with 5 + 10 MBq priming or 15 MBq 177Lu-octreotate as a single dose. Each symbol represents one tumor. C untreated control tumors. Line represents mean of triplicates. *p < 0.05

Back to article page